Veracyte Announces Publication of Data Demonstrating Clinical Utility of Its Envisia Genomic Classifier to Improve IPF DiagnosisBusiness Wire • 12/14/21
Veracyte Announces Further European Reimbursement Expansion for Prosigna Breast Cancer TestBusiness Wire • 11/24/21
Veracyte Announces New Data on Immuno-Oncology Offerings Presented at SITC 2021Business Wire • 11/13/21
Veracyte, Inc. (VCYT) CEO Marc Stapley on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/10/21
Veracyte Announces Immunoscore Colon Cancer Test Included in ESMO Clinical Practice Guidelines Adapted for Pan-AsiaBusiness Wire • 11/05/21
New Publication Reinforces Clinical Utility of Afirma Genomic Sequencing Classifier in Thyroid Cancer DiagnosisBusiness Wire • 11/03/21
Earnings Preview: Veracyte (VCYT) Q3 Earnings Expected to DeclineZacks Investment Research • 11/02/21
Veracyte Announces New Data To Be Presented at SITC 2021 Will Highlight Company's Immuno-Oncology CapabilitiesBusiness Wire • 11/02/21
New Data Demonstrate Clinical Utility of Veracyte's Decipher Prostate Genomic Classifier in Tailoring Treatment for Prostate Cancer Patients Experiencing Progression After SurgeryBusiness Wire • 10/26/21
Data Presented at ASTRO 2021 Validate Prognostic Value of Decipher Prostate Genomic Test in Newly Diagnosed, Clinically High-Risk Prostate CancerBusiness Wire • 10/25/21
New Data to be Presented at ASTRO 2021 Further Validate Clinical Utility of Veracyte's Decipher Prostate Genomic ClassifierBusiness Wire • 10/14/21
New Publication Demonstrates Ability of Veracyte's Decipher Bladder Test to Identify Tumors Most Likely to Respond to ChemotherapyBusiness Wire • 10/13/21
New Clinical Utility Data Confirm Veracyte's Envisia Genomic Classifier Increases Accuracy and Confidence in IPF DiagnosisBusiness Wire • 10/11/21
Veracyte Announces New Expanded Data at CHEST Underscoring Percepta Nasal Swab Test's Ability to Improve Early Lung Cancer AssessmentBusiness Wire • 10/11/21
New Data to be Presented at CHEST 2021 Showcase Clinical Performance of Veracyte's Genomic Diagnostic Tests in Lung Cancer and Interstitial Lung DiseaseBusiness Wire • 10/06/21
Veracyte Announces that New NCCN Guidelines Uniquely Recommend Use of Decipher Prostate Genomic Test Score to Guide Specific Treatment for Men Following Radical ProstatectomyBusiness Wire • 09/14/21
Veracyte Further Strengthens Medical Team with Appointment of Joshua Klopper, M.D., as Medical Director of EndocrinologyBusiness Wire • 09/01/21
Veracyte to Participate in Morgan Stanley 19th Annual Global Healthcare ConferenceBusiness Wire • 08/31/21
Veracyte Named a San Francisco Bay Area “Top Workplace” for Eighth Consecutive YearBusiness Wire • 08/23/21